Revenue
attach_money5M EUR
YoY -60.6%
IPHYFInnate Pharma S.A.$ --
Innate Pharma S.A.
IPHYF
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
analyticsEarnings Summary
FY2025 Q2Updated: 06/30/2025
Operating Income
trending_up-25M EUR
YoY +3.4%
Net Income
verified-21M EUR
YoY +13.8%
EPS
paid-0.25EUR
YoY +19.4%
Revenue
EUR4.9M
MISS
EUR10.2M
EUR4.9M
EUR10.2M
EUR4.9M
Estimate (Forecast)Actual (Actual)
FY2025 Q2 YoY
-7.5M EUR-60.6%
Net Income
EUR-21.3M
BEAT
EUR-24.5M
EUR-21.3M
EUR-24.5M
EUR-21.3M
Estimate (Forecast)Actual (Actual)
FY2025 Q2 YoY
+3.4M EUR+13.8%
Surprise History
ActualEstimate
FY2024MISS